Tianjin Pharmaceutical Da Ren Tang Group Corporation(600329) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

CN Stock MarketDetailed Quotes

600329 Tianjin Pharmaceutical Da Ren Tang Group Corporation

Watchlist

30.76
-1.52-4.71%

Market Closed Mar 31 15:00 CST

23.69BMarket Cap10.63P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Tianjin Pharmaceutical Da Ren Tang Reports Higher Attributable Profit in 2024
MT Newswires01:06 ET
Tianjin Pharma Da Ren Tang Plans Up to 2.46 Billion Yuan Guarantees for Affiliates
MT Newswires19:06 ET
Daren Tang: Daren Tang 2024 Annual Report
SZSI12:00 ET · Announcements
Daren Tang: Summary of Daren Tang\'s 2024 Annual Report
SZSI12:00 ET · Announcements
Daren Tang 2024 Annual Report
SZSI12:00 ET · Announcements
Darren Tang 2024 Annual Report Summary
SZSI12:00 ET · Announcements

Comments

Moomoo AI

Mar 17, 2024 09:49

Tianjin Pharmaceutical Da Ren Tang Group's strong financials hint at potential for long-term value increase despite recent stock price drop. Analysts predict continued earnings expansion due to the company's high ROE, net income growth, and efficient reinvestment.

Could The Market Be Wrong About Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329) Given Its Attractive Financial Prospects?

Moomoo AI

Feb 3, 2024 08:22

Tianjin Pharmaceutical Da Ren Tang Group's low P/E ratio may reflect the market's pessimistic view of its future earnings growth. The weak share price, leading to a lower P/E ratio, suggests that unless the company's earnings outlook improves, the share price may remain suppressed.

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329) Not Doing Enough For Some Investors As Its Shares Slump 29%

Moomoo AI

Dec 6, 2023 12:09

Tianjin Pharmaceutical Da Ren Tang Group's commendable performance is due to reinvestment and high return rate, driving significant earnings growth, with predictions of accelerated earnings.

Are Strong Financial Prospects The Force That Is Driving The Momentum In Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's SHSE:600329) Stock?

bullrider_21

Apr 12, 2023 00:49

$Top Glove (BVA.SG)$ $Riverstone (AP4.SG)$ $Medtecs Intl (546.SG)$ $Aspen (1F3.SG)$ $UGHealthcare (8K7.SG)$
New variant of COVID-19 is soaring in Singapore. Gryphon or XBB is a fast-spreading new subvariant that is part of a 'new class' of Omicron.
MSN
$Tianjin Pharmaceutical Da Ren Tang Group Corporation (600329.SH)$ $Acesian Partners (5FW.SG)$ $Parkson Retail (O9E.SG)$

bullrider_21

Apr 11, 2023 17:36

$TJ DaRenTang USD (T14.SG)$
TJ exceeded its tp of USD1.91.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited produces and sells traditional Chinese medicine, western medicine, health products, and healthcare instruments. The Company also manufactures gene-related biopharmaceutical products. Tianjin Pharmaceutical markets its products under the Great Wall, Cypress, and Health brand names. The Group's businesses cover a wide range of products including Chinese patent medicine, Chinese me...